Skip to content

Clinical trials

Terminated Phase 3 Carcinoma, Renal Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Renal Cell Phase: Phase 3 Status: Terminated Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20081
20101
20122
20172
20181
20191
20201
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche2
AIO-Studien-gGmbH1
Agenus Inc.1
Alliance for Clinical Trials in Oncology1
Argos Therapeutics1
Central European Cooperative Oncology Group1
Centre Leon Berard1
NRG Oncology1
National Cancer Institute (NCI)1
Nektar Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Renal Cell12
Kidney Neoplasms4
Neoplasm Metastasis3
Melanoma2
Brain Neoplasms1
Breast Neoplasms1
Carcinoma, Non-Small-Cell Lung1
Gastrointestinal Neoplasms1
Lung Neoplasms1
Pain1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.